Age-related macular degeneration (AMD) can cause vision loss. Learn about AMD, the importance of diversity in clinical trials.

Announces several updates to enhance and accelerate AXPAXLI registrational program in wet AMD, potentially supporting label flexibility of 6-12 ...

Clinical trials are underway to evaluate the efficacy of combination therapy (photodynamic therapy [PDT] and steroids in the Neovascular AMD, Peri-Ocular Corticosteroids and PDT [NAPP] study ...

Right now, the recently released AMD Ryzen 7 9800X3D AM5 desktop processor is back in stock at Amazon at its retail price of $479 shipped. This is the official launch price with zero markup ...

Since these landmark trials, physicians have tried several different treatment regimens to determine the optimal treatment plan for patients with exudative AMD. These alternative dosing regimens ...

This trial is a key step in Opthea's efforts to develop new treatments for wet AMD, where existing therapies often fail to provide optimal visual improvements. The company's Phase 3 program aims ...

The second thing we want from AMD monitoring is to detect conversion from dry to wet AMD as early as possible. We know that about 15% of patients with dry AMD will eventually convert to exudative ...

A small-incision second-generation implantable miniature telescope can improve distance and near vision in patients with late-stage AMD with little impact on the corneal endothelium. The ...

Wet AMD treatments can be costly, but Medicare covers some options. Knowing what Medicare covers and what it doesn’t can help you choose the best treatments for your budget. Age-related macular ...

Wet age-related macular degeneration (AMD) is an eye disease that can lead to loss of central vision. People with wet AMD may need help with daily tasks, managing their condition, and staying social.